Somnomed Ltd
ASX:SOM
Somnomed Ltd
ASX:SOM
Price:
0.25 AUD
16.28%
Market Closed
Updated:
May 14, 2024
Somnomed Ltd
Selling, General & Administrative
|
Somnomed Ltd
Selling, General & Administrative Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Selling, General & Administrative
-AU$55.7m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-17%
|
|
|
ImpediMed Ltd
ASX:IPD
|
Selling, General & Administrative
-AU$29.3m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-12%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Selling, General & Administrative
-AU$21.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-10%
|
|
|
Cochlear Ltd
ASX:COH
|
Selling, General & Administrative
-AU$873.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-13%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Selling, General & Administrative
-AU$5.1m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-17%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Selling, General & Administrative
-AU$8.6m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-86%
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Selling, General & Administrative?
Selling, General & Administrative
-55.7m
AUD
-55.7m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Selling, General & Administrative amounts to -55.7m AUD.
What is Somnomed Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-17%
-17%
Over the last year, the Selling, General & Administrative growth was -31%. The average annual Selling, General & Administrative growth rates for Somnomed Ltd have been -32% over the past three years , -11% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
